These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 11587128)

  • 41. [Low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol in coronary artery disease].
    Halilović E; Kabil E; Ljuca F; Nuhbegović S; Berbić S; Halilović E
    Med Arh; 2007; 61(2 Suppl 1):7-10. PubMed ID: 21553440
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LDL-cholesterol and HDL-cholesterol concentrations decrease during the day.
    Miida T; Nakamura Y; Mezaki T; Hanyu O; Maruyama S; Horikawa Y; Izawa S; Yamada Y; Matsui H; Okada M
    Ann Clin Biochem; 2002 May; 39(Pt 3):241-9. PubMed ID: 12038599
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simple and practical sandwich-type enzyme immunoassay for human oxidatively modified low density lipoprotein using antioxidized phosphatidylcholine monoclonal antibody and antihuman apolipoprotein-B antibody.
    Kohno H; Sueshige N; Oguri K; Izumidate H; Masunari T; Kawamura M; Itabe H; Takano T; Hasegawa A; Nagai R
    Clin Biochem; 2000 Jun; 33(4):243-53. PubMed ID: 10936581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Ear lobe crease as a factor of potential risk for coronary artery disease?--World news review and own research].
    Dytfeld D; Leśna J; Protasewicz A; Sarnowski W; Dyszkiewicz W; Paradowski S
    Pol Arch Med Wewn; 2002 Jul; 108(1):633-8. PubMed ID: 12412407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A monoclonal antibody-based enzyme immunoassay for the measurement of native and glycated apolipoprotein B-containing particles.
    Calvo C; Bustos P; Giraudo P; Ulloa N; Sepulveda J; Verdugo C; Toledo L
    J Atheroscler Thromb; 1997; 4(1):45-9. PubMed ID: 9583354
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of human asialo-alpha(1)-acid glycoprotein using a heterosandwich immunoassay in conjunction with the light addressable potentiometric sensor.
    Dill K; Bearden DW
    Glycoconj J; 1996 Aug; 13(4):637-41. PubMed ID: 8872121
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An antibody-lectin sandwich assay for asialo-LDL levels in atherosclerosis.
    McDowell A; Young IS; Wisdom GB
    Biochem Soc Trans; 1998 Feb; 26(1):S16. PubMed ID: 10909774
    [No Abstract]   [Full Text] [Related]  

  • 50. [Diagnostic value of serum concentrations of apolipoprotein B in male patients with suspected ischemic heart disease].
    Pataraia SA; Preobrazhenskiĭ DV; Anisimova OIu; Samko AN
    Kardiologiia; 2005; 45(7):56-7. PubMed ID: 16091663
    [No Abstract]   [Full Text] [Related]  

  • 51. Elevation of serum asialo-alpha(1) acid glycoprotein concentration in patients with hepatic cirrhosis and hepatocellular carcinoma as measured by antibody-lectin sandwich assay.
    Song EY; Kim KA; Kim YD; Lee EY; Lee HS; Kim HJ; Ahn BM; Choe YK; Kim CH; Chung TW
    Hepatol Res; 2003 Aug; 26(4):311-317. PubMed ID: 12963431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apolipoproteins as markers and managers of coronary risk.
    Chan DC; Watts GF
    QJM; 2006 May; 99(5):277-87. PubMed ID: 16504986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Measurement of asialylated LDL in the blood of patients with coronary artery disease by antibody-lectin sandwich assay.
    Mcdowell A; Young IS; Wisdom GB
    Ann Clin Biochem; 2001 Sep; 38(Pt 5):499-508. PubMed ID: 11587128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
    McDowell A; Young IS; Wisdom GB
    J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modified (desialylated) low-density lipoprotein measured in serum by lectin-sorbent assay.
    Tertov VV; Sobenin IA; Orekhov AN
    Clin Chem; 1995 Jul; 41(7):1018-21. PubMed ID: 7600681
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.